Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (3): 189-194.doi: 10.6040/j.issn.1673-3770.0.2021.512

Previous Articles     Next Articles

Postoperative efficacy of proton pump inhibitor in the treatment of difficult-to-treat rhinosinusitis with laryngopharyngeal reflux

ZENG Xianting, WANG Guangke, SUN Zhanwei, WU Tianyi, LI Shichao, WANG Weiwei   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, Henan Provincial People's Hospital/People's Hospital of Henan University, Henan Provincial People's Hospital, Zhengzhou 540000, Henan, China
  • Published:2022-06-15

Abstract: Objective To explore the clinical effect of proton pump inhibitor(PPI)after the operation for difficult-to-treat rhinosinusitis(DTRS)with laryngopharyngeal reflux(LPR). Methods A total of 42 patients with DTRS with LPR were collected, of which 21 patients were given standard PPI treatment for 8 weeks plus routine perioperative treatment(experimental group), and 21 patients were given routine perioperative treatment(control group). The general information, peripheral blood eosinophil count, VAS score, peripheral blood IgE, Lund-Kennedy nasal endoscopy score, Lund-Mackay CT score, reflux symptom index scale(RSI)and reflux sign score(RFS)were compared between the two groups. The nasal endoscopic score, sinus CT score, VAS score, RSI and RFS scores of both groups were collected at the 1st, 3rd, 6th and 12th month after operation. Differences between the throat symptom score and objective examination results of both groups were analyzed, and the postoperative clinical effect of PPI therapy on DTRS with LPR was evaluated. Results After 1 year continuous follow-up, RFS, RSI, endoscopic score, sinus CT score and VAS scores were significantly lower compared with the control group [(2.57±1.54)points vs.(3.57±1.60)points,P=0.045<0.05;(2.86±1.59)points vs.(4.62±1.77)points,P=0.002<0.05;(3.43±1.93)points vs.(5.43±3.11)points, P=0.017;(1.00±0.78)points vs(2.10±1.09)points, P=0.018<0.05;(0.67±0.66)points vs.(1.24±0.83)points,P=0.001<0.05] Conclusion PPI after operation for DTRS with LPR can obviously improve nasal symptoms, improve quality of life and reduce the symptoms and signs related to throat reflux, which can be used as an individualized treatment for these patients.

Key words: Difficult-to-treat rhinosinusitis, Proton pump inhibitors, Laryngopharyngeal reflux, Individualized treatment, Endoscopy, Follow-up

CLC Number: 

  • R765.4+1
[1] Wreesmann VB, Fokkens WJ, Knegt PP. Refractory chronic sinusitis: evaluation of symptom improvement after Denker's procedure[J]. Otolaryngol Head Neck Surg, 2001, 125(5): 495-500. doi:10.1067/mhn.2001.119484.
[2] Desrosiers M. Refractory chronic rhinosinusitis: pathophysiology and management of chronic rhinosinusitis persisting after endoscopic sinus surgery[J]. Curr Allergy Asthma Rep, 2004, 4(3): 200-207. doi:10.1007/s11882-004-0027-z.
[3] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001. Chinese guidelines for diagnosis and treatment of chronic rhinosinusitis(2018)[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001.
[4] Massoth L, Anderson C, McKinney KA. Asthma and chronic rhinosinusitis: diagnosis and medical management[J]. Med Sci(Basel), 2019, 7(4): 53. doi:10.3390/medsci7040053.
[5] 韩德民. 正确理解难治性鼻-鼻窦炎[J]. 中华耳鼻咽喉头颈外科杂志, 2013, 48(2): 113-114. doi:10.3760/cma.j.issn.1673-0860.2013.02.012.
[6] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(Suppl S29): 1-464. doi:10.4193/Rhin20.600.
[7] 中华耳鼻咽喉头颈外科杂志编辑委员会咽喉组, 中华医学会耳鼻咽喉头颈外科学分会咽喉学组.咽喉反流性疾病诊断与治疗专家共识(2015年)[J]. 中华耳鼻咽喉头颈外科杂志, 2016,51(5):324-326. doi: 10.3760/cma/j/issn/1673-860.2016.05.002.
[8] Stevens WW, Peters AT, Tan BK, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis[J]. J Allergy Clin Immunol Pract, 2019, 7(8): 2812-2820.e3. doi:10.1016/j.jaip.2019.05.009.
[9] Bohnhorst I, Jawad S, Lange BB, et al. Prevalence of chronic rhinosinusitis in a population of patients with gastroesophageal reflux disease[J]. Am J Rhinol Allergy, 2015, 29(3): e70-e74. doi:10.2500/ajra.2015.29.4167.
[10] Arslan H, Çandar T, Kuran S, et al. New inflammatory parameters in laryngopharyngeal reflux[J]. J Laryngol Otol, 2016, 130(9): 878-882. doi:10.1017/S0022215116008653.
[11] 慕婷婷, 杨玉娟, 张宇, 等. IL-36在慢性鼻-鼻窦炎伴鼻息肉中的研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 114-118. doi: 10.6040/j.issn.1673-3770.0.2020.146. MU Tingting, YANG Yujuan, ZHANG Yu, et al. Research progress of IL-36 in chronic rhinosinusitis with nasal polyps[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 114-118. doi: 10.6040/j.issn.1673-3770.0.2020.146.
[12] Mikami DJ, Murayama KM. Physiology and pathogenesis of gastroesophageal reflux disease[J]. Surg Clin North Am, 2015, 95(3): 515-525. doi:10.1016/j.suc.2015.02.006.
[13] Agrawal N, Yadlapati R, Shabeeb N, et al. Relationship between extralaryngeal endoscopic findings, proton pump inhibitor(PPI)response, and pH measures in suspected laryngopharyngeal reflux[J]. Dis Esophagus, 2019, 32(4): doy072. doi:10.1093/dote/doy072.
[14] 孙娜, 陈晓平. 咽喉反流与耳鼻咽喉科疾病[J]. 山东大学耳鼻喉眼学报, 2016, 30(6): 85-89. doi: 10.6040/j.issn.1673-3770.0.2016.213. SUN Na, CHEN Xiaoping. Laryngopharyngeal reflux and otorhinolaryngology diseases[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2016, 30(6): 85-89. doi: 10.6040/j.issn.1673-3770.0.2016.213.
[15] 梁芳芳. 咽喉反流相关鼻部疾病研究进展[J]. 中国耳鼻咽喉颅底外科杂志, 2015, 21(3): 264-266. doi:10.11798/j.issn.1007-1520.201503031.
[16] Chong LY, Head K, Hopkins C, et al. Saline irrigation for chronic rhinosinusitis[J]. Cochrane Database Syst Rev, 2016, 4(4): CD011995. doi:10.1002/14651858.CD011995.pub2.
[17] Sanan A, Rabinowitz M, Rosen M, et al. Topical therapies for refractory chronic rhinosinusitis[J]. Otolaryngol Clin North Am, 2017, 50(1): 129-141. doi:10.1016/j.otc.2016.08.011.
[18] Piromchai P, Kasemsiri P, Laohasiriwong S, et al. Chronic rhinosinusitis and emerging treatment options[J]. Int J Gen Med, 2013, 6: 453-464. doi:10.2147/ijgm.s29977.
[19] 王迪, 张慧慧, 文连姬, 等. 咽喉反流与老年患者耳鼻喉科疾病相关性研究进展[J]. 中国老年学杂志, 2018, 38(15): 3816-3819. doi:10.3969/j.issn.1005-9202.2018.15.090.
[20] Southwood JE, Hoekzema CR, Samuels TL, et al. The impact of pepsin on human nasal epithelial cells in vitro: a potential mechanism for extraesophageal reflux induced chronic rhinosinusitis[J]. Ann Otol Rhinol Laryngol, 2015, 124(12): 957-964. doi:10.1177/0003489415593556.
[21] 吴迪盼盼, 崔新华, 郭颖, 等. 窄带成像技术在咽喉反流诊断中的优势应用[J]. 山东大学耳鼻喉眼学报, 2021, 35(3):31-36. doi: 10.6040/j.issn.1673-3770.1.2020.108. WU DIpanpan, CUI Xinhua, GUO Ying, et al. Narrow band imaging might contribute to the diagnosis of laryngopharyngeal refiux[J].Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(3):31-36. doi: 10.6040/j.issn.1673-3770.1.2020.108.
[22] Gupta R, Sataloff RT. Laryngopharyngeal reflux: current concepts and questions[J]. Curr Opin Otolaryngol Head Neck Surg, 2009, 17(3): 143-148. doi:10.1097/MOO.0b013e32832b2581.
[23] 郎永耀, 杨云, 刘晴, 等. 咽喉反流性疾病的影响因素及治疗效果分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 119-123. doi: 10.6040/j.issn.1673-3770.0.2018.472. LANG Yongyao, YANG Yun, LIU Qing, et al. Analysis of influencing factors and observation of therapeutic effects in patients with laryngopharyngeal reflux disease[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 119-123. doi: 10.6040/j.issn.1673-3770.0.2018.472.
[24] 齐智伟, 陆鸿略, 张洁, 等. 奥美拉唑治疗反流性咽喉炎不同疗程的疗效评价[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(9): 693-697. doi:10.13201/j.issn.1001-1781.2018.09.012. QI Zhiwei, LU Honglue, ZHANG Jie, et al. Effect of different course of omeprazole in the treatment of laryngopharyngeal reflux[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2018, 32(9): 693-697. doi:10.13201/j.issn.1001-1781.2018.09.012.
[25] Guo H, Ma H, Wang J. Proton pump inhibitor therapy for thetreatment of laryngopharyngeal reflux: A Meta-analysis of randomized controlled trials[J]. J Clin Gastroenterol, 2016, 50(4): 295-300. doi: 10.1097/MCG.0000000000000324.
[1] CHENG Zhuo, LIANG Hui, XING Lumin. Research progress and prospect analysis of deep learning technology in the application of pharyngeal and laryngeal endoscopy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 112-119.
[2] LIU Ziqi, HUANG Jiali, WANG Liqin, CHEN Xi, ZHANG Liqing, ZHOU Han. Application of narrow band imaging endoscopy combined with voice acoustic analysis in the differential diagnosis of vocal cord leukoplakia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 87-96.
[3] LI Xiaoyu, WANG Binchen, XU Dapeng, WANG Yanhua, DU Pinggong, ZHANG Qingquan. Effectiveness of transnasal and transoral fenestration in the treatment of maxillary bone cysts [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 72-78.
[4] SUN Le, ZHANG Yunyun, LIU Hao, YE Jingying, WU Yanqiao. Endoscopic-assisted resection of giant pleomorphic adenoma in the palate via the oral and nasal approach: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 117-122.
[5] SHI Zhonggang, CAI Xiaolan, LI Xuezhong, ZHANG Liqiang, FENG Xin. Maxillary cyst with inverted papilloma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 123-129.
[6] WU Wei, WANG Lei, CHEN Sheng, LI Lianyong, WANG Gang. Multidisciplinary research and advances in gastro-oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 1-14.
[7] LIU Lianlian, LI Jinrang. Obstructive sleep apnea and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 15-22.
[8] ZHANG Li, ZHANG Mengru, Alimire Aierken, QIU Zhongmin. Role of pharyngeal reflux in common respiratory diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 23-29.
[9] HU Zhiwei, CHEN Dong, YANG Dong, WU Jimin. Diagnosis and treatment of gastroesophageal airway reflux disease: based on related consensus and guidelines from 2020 to 2024 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 30-38.
[10] ZHAO Jianing, CUI Yuanxin, WANG Dan, ZHAO Ming. Exploration of the relationship between laryngopharyngeal reflux and recurrent respiratory papilloma and its mechanism [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 39-45.
[11] ZHANG Shan, CHEN Qiu, ZHOU Fangwei, MA Yifei. Research progress of biomarkers in laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 46-54.
[12] ZHOU Shitong, YANG Yanyan, YANG Yucheng, FANG Hongyan. Pepsin and laryngopharyngeal reflux disease: from pathogenic mechanisms to potential risk factors for pharyngeal and laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 55-60.
[13] XI Xiaoyu, SUI Xinke, CHEN Sheng, LI Lianyong, ZHONG Changqing. Endoscopic treatment of laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 61-65.
[14] NIU Yanyan, GU Wei, JIN Xiaofeng, HUO Hong, YANG Dahai, CUI Tingting, WANG Jian. Expression analysis of pepsin in vocal cord leukoplakia tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 66-70.
[15] WANG Lei, WANG Gang, SUN Zhezhe, LIU Hongdan, HAN Haolun, LI Baowei, ZHANG Xiaoli, WU Wei. Correlations between vocal cord hyperplastic lesions, vocal cord leukoplakia, chronic laryngopharyngitis, and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 71-77.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!